Inventor · disambiguated record
Bernard Cuenoud
Also filed as: CUENOUD BERNARD
23 granted patents·18 pending applications·385 citations·filing 1995–2025
96Inventor score
Top patents by PatentIndex Score
41 records- 0194US6800643B2Mixtures for organic compounds for the treatment of airway diseasesNOVARTIS AG·Filed 2001·Granted Oct 5, 2004·59 cites·20 claims
- 0294US6537524B1Combinations of formoterol and a tiotropium saltNOVARTIS AG·Filed 2001·Granted Mar 25, 2003·96 cites·20 claims
- 0392US11000496B2Medium chain triglyceride compositionsNESTEC SA·Filed 2016·Granted May 11, 2021·3 cites·17 claims
- 0491US6878721B1Beta2-adrenoceptor agonistsNOVARTIS AG·Filed 2000·Granted Apr 12, 2005·29 cites·19 claims
- 0589US7622483B2β2-adrenoceptor agonistsNOVARTIS AG·Filed 2005·Granted Nov 24, 2009·8 cites·7 claims
- 0687US8067437B2Beta-2-adrenoreceptor agonistsCUENOUD BERNARD·Filed 2010·Granted Nov 29, 2011·7 cites·10 claims
- 0787US7820694B2Beta-2-adrenoreceptor agonistsNOVARTIS AG·Filed 2009·Granted Oct 26, 2010·5 cites·8 claims
- 0887US6921757B2Organic compoundsNOVARTIS AG·Filed 2001·Granted Jul 26, 2005·34 cites·20 claims
- 0987US5910408ACatalytic DNA having ligase activityGEN HOSPITAL CORP·Filed 1995·Granted Jun 8, 1999·97 cites·17 claims
- 1086US8796307B2Beta2-adrenoreceptor agonistsCUENOUD BERNARD·Filed 2013·Granted Aug 5, 2014·5 cites·7 claims
- 1185US12251367B2Medium chain triglyceride compositionsNESTLE SA·Filed 2023·Granted Mar 18, 2025·0 cites·13 claims
- 1285US8283362B2Beta-2-adrenoreceptor agonistsCUENOUD BERNARD·Filed 2011·Granted Oct 9, 2012·5 cites·20 claims
- 1385US2025073195A1Medium chain triglyceride compositionsNESTLE SA·Filed 2024·Application pending·0 cites
- 1484US11857527B2Medium chain triglyceride compositionsNESTLE SA·Filed 2021·Granted Jan 2, 2024·1 cites·14 claims
- 1583US8404684B2Inhibitors of phosphatidylinositol 3-kinaseBRUCE IAN·Filed 2011·Granted Mar 26, 2013·9 cites·10 claims
- 1681US6670468B12′-substituted nucleosides and oligonucleotide derivativesNOVARTIS AG·Filed 2001·Granted Dec 30, 2003·12 cites·4 claims
- 1779US8658673B2BETA2-adrenoreceptor agonistsCUENOUD BERNARD·Filed 2013·Granted Feb 25, 2014·2 cites·14 claims
- 1875US7008951B2Mixtures or organic compounds for the treatment of airway diseasesNOVARTIS AG·Filed 2004·Granted Mar 7, 2006·5 cites·6 claims
- 1974US7622484B2Mixtures or organic compounds for the treatment of airway diseasesNOVARTIS AG·Filed 2005·Granted Nov 24, 2009·1 cites·8 claims
- 2072US7745462B2Quinoline-2-one derivatives for the treatment of airways diseasesNOVARTIS AG·Filed 2004·Granted Jun 29, 2010·7 cites·12 claims
- 2168US9040559B2BETA2-adrenoceptor agonistsNOVARTIS AG·Filed 2014·Granted May 26, 2015·0 cites·13 claims
- 2267US2010068288A1Mixtures or organic compounds for the treatment of airway diseasesCUENOUD BERNARD·Filed 2009·Application pending·0 cites
- 2364US2025325511A1Dietary butyrateNESTLE SA·Filed 2025·Application pending·0 cites
- 2463US8436017B2Beta-2-adrenoreceptor agonistsCUENOUD BERNARD·Filed 2012·Granted May 7, 2013·0 cites·20 claims
- 2563US2023285321A1Compositions and methods using a combination of autophagy inducer and high protein for induction of autophagyNESTLE SA·Filed 2023·Application pending·0 cites
- 2662US2025134918A1Compositions and methods using a nicotinamide adenine dinucleotide (nad+) precursor and at least one ketone or ketone precursorNESTLE SA·Filed 2024·Application pending·0 cites
- 2758US2007249586A1Benzothiazole derivatives having beta-2-adrenoreceptor agonist activityCUENOUD BERNARD·Filed 2007·Application pending·0 cites
- 2858US2015065490A1Organic compoundsCUENOUD BERNARD·Filed 2014·Application pending·0 cites
- 2956US2012108555A1Mixtures or Organic Compounds for the Treatment of Airway DiseasesCUENOUD BERNARD·Filed 2012·Application pending·0 cites
- 3056US2021228526A1Mct formulations for increasing ketone exposure and methods of making and using such formulationsNESTLE SA·Filed 2019·Application pending·0 cites
- 3156US2022184022A1Dietary butyrateNESTLE SA·Filed 2020·Application pending·0 cites
- 3254US2005159374A12'-Substituted nucleosides and oligonucleotide derivativesFiled 2003·Application pending·0 cites
- 3352US2006106075A1Benzothiazole derivatives having beta-2-adrenoreceptor agonist activityCUENOUD BERNARD·Filed 2003·Application pending·0 cites
- 3452US2006083692A1Combination of formoterol and a tiotropium saltHASSAN IAN F·Filed 2005·Application pending·0 cites
- 3551US2007032487A1Inhibitors of phosphatidylinositol 3-kinaseBRUCE IAN·Filed 2004·Application pending·0 cites
- 3650US2013172349A1Inhibitors of phosphatidylinositol 3-kinaseNOVARTIS AG·Filed 2013·Application pending·0 cites
- 3749US2003125350A1Combination of formoterol and a tiotropium saltFiled 2003·Application pending·0 cites
- 3848US12403152B2Compositions and methods using a nicotinamide adenine dinucleotide (NAD+) precursor and at least one ketone or ketone precursorNESTLE SA·Filed 2019·Granted Sep 2, 2025·0 cites·4 claims
- 3943US2021085624A1Compositions and methods using a combination of autophagy inducer and high protein for induction of autophagyNESTLE SA·Filed 2018·Application pending·0 cites
- 4043US2020384064A1Compositions and methods using high protein for induction of autophagyNESTLE SA·Filed 2018·Application pending·0 cites
- 4140US8017608B25-Phenylthiazole derivatives and their use as p13 kinase inhibitorsNOVARTIS AG·Filed 2004·Granted Sep 13, 2011·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Bernard Cuenoud files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →